Plus   Neg

Halma Acquires MicroSurgical Technology For About $57 Mln

Safety, health and environment technology group Halma plc (HLMA.L), Wednesday announced the acquisition of ophthalmic surgical products provider MicroSurgical Technology, Inc. (MST), for $57 million in cash in addition to a $2 million for cash retained in business. The acquisition, expected to add to earnings immediately, has been funded using existing cash and debt facilities, said the company in a statement.

Further, MicroSurgical is entitled to a payment of another $43 million, if the earnings for the 2 year period to March 2015 surpasses a pre-determined amount.

MST, set to join Halma 's Health and Analysis sector posted full-year 2011 revenue of $20.4 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Samsung Electronics Co Ltd (SMSN.L, SSNNF.OB, SSNLF.OB) expects that its first-quarter operating profit will increase about 2.73 percent from last year, sales will also increase 4.98 percent. JPMorgan Chase CEO Jamie Dimon said it expects the bank's earnings to be "down meaningfully" in 2020 due to the disruptions created by coronavirus pandemic. He also noted that the U.S. was not adequately prepared for the pandemic. In his annual letter to the company's shareholders, Dimon said that the bank's board may consider suspending the dividend in an extremely adverse scenario. The U.S. Food and Drug Administration launched a national effort to facilitate the development of blood-related therapies to combat the ongoing coronavirus (COVID-19) pandemic. The FDA is focused on two investigational therapies derived from human blood called convalescent plasma and hyperimmune globulin, which are antibody-rich blood products made from blood donated by people who have recovered.
Follow RTT